- Home
- LILAK vs BBNX Comparison
LILAK vs BBNX Comparison
Compare LILAK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILAK
- BBNX
- Stock Information
- Founded
- LILAK 2017
- BBNX 2015
- Country
- LILAK Bermuda
- BBNX United States
- Employees
- LILAK N/A
- BBNX N/A
- Industry
- LILAK Cable & Other Pay Television Services
- BBNX Medical/Dental Instruments
- Sector
- LILAK Telecommunications
- BBNX Health Care
- Exchange
- LILAK Nasdaq
- BBNX Nasdaq
- Market Cap
- LILAK 1.1B
- BBNX 967.6M
- IPO Year
- LILAK N/A
- BBNX 2025
- Fundamental
- Price
- LILAK $8.44
- BBNX $22.26
- Analyst Decision
- LILAK Hold
- BBNX Strong Buy
- Analyst Count
- LILAK 2
- BBNX 10
- Target Price
- LILAK $7.85
- BBNX $26.10
- AVG Volume (30 Days)
- LILAK 1.1M
- BBNX 1.2M
- Earning Date
- LILAK 11-05-2025
- BBNX 11-06-2025
- Dividend Yield
- LILAK N/A
- BBNX N/A
- EPS Growth
- LILAK N/A
- BBNX N/A
- EPS
- LILAK N/A
- BBNX N/A
- Revenue
- LILAK $4,409,700,000.00
- BBNX $78,022,000.00
- Revenue This Year
- LILAK $1.37
- BBNX $42.80
- Revenue Next Year
- LILAK N/A
- BBNX $34.58
- P/E Ratio
- LILAK N/A
- BBNX N/A
- Revenue Growth
- LILAK N/A
- BBNX 550.45
- 52 Week Low
- LILAK $4.23
- BBNX $8.89
- 52 Week High
- LILAK $10.67
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- LILAK 60.41
- BBNX 56.75
- Support Level
- LILAK $8.24
- BBNX $19.07
- Resistance Level
- LILAK $8.58
- BBNX $21.08
- Average True Range (ATR)
- LILAK 0.24
- BBNX 1.44
- MACD
- LILAK -0.00
- BBNX -0.45
- Stochastic Oscillator
- LILAK 86.14
- BBNX 52.15
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.